Markets

(RTTNews) – Belden Inc. (BDC), a supplier of specialty networking solutions, on Wednesday reported attributable net income for the third quarter of $17.00 million or $0.38 per share, compared to net loss of $297.98 million or $6.70 per share in the year-ago period. Adjusted earnings for the quarter were $0.72 per share, compared to $1.19 per share in the prior-year quarter. Revenues for the quarter declined to $475.8 million from $533.1 million in the prior-year period. On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.61 per share for the quarter on revenues of $445.78 million. Analysts’ estimates typically exclude special items. Looking ahead to the fourth quarter, Belden expects adjusted earnings in a range of $0.63 to $0.78 per share and revenues in a range of $460 million to $485 million. The Street expects earnings of $0.80 per share on revenues of $471.28 million. For the full year ending December 31, 2020, the company expects adjusted earnings of $2.47 to $2.62 per share and revenues in a range of $1.824 billion to $1.849 billion. Analysts expect earnings of $2.52 per share on revenues of $1.81 billion for the year.

Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the third quarter 2020 financial results and provide a corporate update on Wednesday, November 4, 2020 at 4:30 p.m. Eastern/1:30 p.m. Pacific. Conference Call and Webcast: Wednesday, November 4, 2020 @ 4:30 p.m. Eastern/1:30 p.m. Pacific Domestic: (877) 837-3910, Conference ID# 1281757 International: (973) 796-5077, Conference ID# 1281757 The conference call will also be available from the Investor Relations section of the company’s website at https://investor.sppirx.com/events-and-presentations and will be archived there shortly after the live event. About Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. Spectrum has a strong track record of successfully executing across the biopharmaceutical business model, from in-licensing and acquiring differentiated drugs, clinically developing novel assets, successfully gaining regulatory approvals and commercializing in a competitive healthcare marketplace. Spectrum has a late-stage pipeline with novel assets that serve areas of unmet need. This pipeline has the potential to transform the company in the near future.

Dublin, Oct. 28, 2020 (GLOBE NEWSWIRE) — The “Glucaric Acid Market, Size, Share, Outlook and COVID-19 Strategies, Global Forecasts from 2019 to 2026” report has been added to ResearchAndMarkets.com’s offering.As the Glucaric Acid industry shifts, the report presents the emerging market trends, factors driving the Glucaric Acid market growth, and potential opportunities over the forecast period. The trends underpinning the profitability of Glucaric Acid companies are shifting rapidly, forcing companies to carefully align their strengths in synchronization with Glucaric Acid industry trends.To avoid getting left behind in an intensive competitive Glucaric Acid market, global companies need a new approach to ensure they create value in this environment. Amid increasing activities of M&A and growing activist-investor activity, Glucaric Acid companies must strengthen their capabilities to maintain their market shares in the Glucaric Acid industry.The report presents an introduction to the Glucaric Acid market in 2020, analyzing the COVID-19 impact both quantitatively and qualitatively. It presents the strategies being adopted by leading Glucaric Acid companies, emerging market trends, Glucaric Acid market drivers, challenges, and potential opportunities to 2026. The market attractiveness index is also included to assess the impact of suppliers, buyers, competitive landscape, new entrants, and substitutes on the Glucaric Acid

Dublin, Oct. 28, 2020 (GLOBE NEWSWIRE) — The “Aluminium Flat Products – Global Market Outlook (2019-2027)” report has been added to ResearchAndMarkets.com’s offering.Global Aluminium Flat Products Market accounted for $54.6 billion in 2019 and is expected to reach $93.81 billion by 2027, growing at a CAGR of 7% during the forecast period.Increasing demand in the construction industry, government guidelines to promote lightweight materials in the automotive industry, and increasing penetration of aluminium in vehicles on account of its lightweight properties are some of the factors propelling the growth of the market. However, volatility in raw material prices is hampering the growth of the market.Aluminium and its various alloy products are lightweight in nature and also have characteristics such as corrosion resistance, ductility, and high strength. Aluminium flat products are produced from flat rolling processing method which turns an aluminium ingot known as slab into the thinner product or a plate. These aluminium flat products also show excellent flexibility and rigidity with a reduction in temperature.Based on the end-user, the automotive & transportation segment is anticipated to hold considerable market share during the forecast period owing to the increasing use of these products in aircraft and vehicles on account of its

NEW YORK, Oct. 28, 2020 /PRNewswire/ — The Rockefeller Foundation will commit USD1 billion over the next three years to catalyze a more inclusive, green recovery from the COVID-19 pandemic. Building on current efforts and long-standing programs, the Foundation will focus on two key areas: catalyzing billions of dollars in private and concessional investments to scale distributed renewable energy across developing countries; and ensuring more equitable access to COVID-19 tests and vaccines, science-based tools, and data to fight the pandemic, while strengthening public health systems to prevent future outbreaks. In addition to this unique, one-time commitment of additional resources, The Rockefeller Foundation’s efforts and energies, as a whole, will be rededicated and reoriented toward improving the lives of the world’s poorest people and addressing inequities made worse by this virus. “There’s no going back to the past, to before-COVID. We need to reimagine the future we want,” said Dr. Rajiv J. Shah, President of the Rockefeller Foundation. “To meet this moment, we must leverage all our resources and relationships to build an equitable, sustainable future, where everyone has the opportunity to realize their full potential and climate disaster is avoided. The time to act is right now to make sure vulnerable

Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that the last patient in the low-dose cohort has completed six months of NOX-A12 therapy in the Phase 1/2 brain cancer clinical trial. The study investigates three dose regimens of NOX-A12 (200, 400 and 600 mg/week), each combined with external beam radiotherapy in newly diagnosed MGMT1 promoter unmethylated glioblastoma patients, a difficult-to-treat brain cancer. Patients participating in the study would not have benefitted clinically from the standard of care chemotherapy due to their MGMT promoter methylation status. They also all had tumor tissue remaining after surgical resection before being recruited into the study. Tumor volume reductions were observed in two of three patients during the six-month treatment, and in the third patient in the period after a second surgery following continued NOX-A12 treatment. Maximum tumor volume reductions were 6% and 60% for the first two patients. The third patient experienced 23% tumor volume reduction relative to the post-second surgery baseline. Tumor volume reductions were reported as the average of two independent central MRI readers and results included unscheduled scans. Two of three patients

(RTTNews) – Asahi Group Holdings Ltd (ASBRF.PK) announced Wednesday that Asahi Beverages Pty Ltd has agreed to divest part of its alcohol brands to Dutch brewer Heineken Holding N.V. (HKHHF.PK). The financial terms of the deal were not disclosed. The Beer And Cider brands are owned or licensed by Carlton & United Breweries or CUB. These include Strongbow, Little Green and Bonamy’s, plus Stella Artois and Beck’s. The sale is part of the process under the resolution of issues approved by the Australian Competition and Consumer Commission or ACCC for the acquisition of the CUB business from Anheuser-Busch InBev. In April, Australia’s competition regulator had said that it would not oppose Asahi Group’s proposed acquisition of CUB from Anheuser-Busch InBev, as Asahi agreed to divest two of its beer brands and three of its cider brands. In December 2019, the regulator had raised concerns over Asahi’s proposed $11 billion acquisition of CUB business. Asahi now said the completion of the sale to Heineken is subject to approval by the ACCC and the Foreign Investment Review Board of Australia and is expected to be approved by the end of 2020.

(RTTNews) – Kentucky-based tobacco company Turning Point Brands Inc. said it has invested $15 million in Los Angeles-based cannabis brand dosist. Turning Point Brands or TPB has also signed an exclusive co-development and distribution agreement of a new national cannabidiol or CBD brand to be created in partnership with dosist’s THC-free business unit. The partnership will combine TPB’s sales and operations infrastructure with dosist’s expertise in product innovation, marketing and brand development. The new brand will be exclusively distributed by TPB, which services more than 180,000 points of sale in the U.S. TPB said it also has an option to invest an additional $15 million in dosist at pre-determined terms within the next twelve months. TPB’s investment will be used by dosist’s THC-free and Canadian business units and cannot be for any cannabis or cannabis-related operations in the U.S. unless such operations comply with U.S. laws. “The cannabis market is exploding and now is the opportune time to invest in the space and significantly expand our addressable market. With its leadership in results-oriented plant-based formulas and dose control technology, global recognition, consumer trust and scalability, dosist was the clear choice to be our new partner in this critical growth market,”

SHANGHAI, Oct. 28, 2020 /PRNewswire/ — Shanghai Electric (the “Company”) (SEHK: 02727, SSE: 601727), the world’s leading manufacturer and supplier of electric power generation equipment, industrial equipment and integration services, has reached another milestone with the start of the soldering process of the heating surface of a boiler of Thar Coal Block-1 2x660MW Power Plant Project in Pakistan. The Company also held a soldering competition among welders to encourage and empower local workers to demonstrate their professional expertise under the guidance spirit of pursuing perfection. A soldering contest with a total number of 8 Chinese and Pakistani welders on-site was conducted as part of the ongoing training, and the top three places were taken by a Chinese welder and two Pakistani welders. “We’re glad to see our welders accomplish difficult soldering tasks in the contest, and we see this as a part of our ongoing training for workers to deliver quality results,” Qian Xiaolei, PR Manager of the project, said. The participants were required to complete multiple missions within 40 minutes, including tasks such as switching welding machines, welding debugging, plate splicing and plate vertical welding. The participants were evaluated by 12 key aspects such as weld forming, weld residual

(RTTNews) – Indian shares are likely to open lower on Wednesday after posting strong gains in the previous session on hopes of higher foreign inflows. Finance Minister Nirmala Sitharaman on Tuesday said economic activity had picked up in the country after the easing of pandemic restrictions but GDP growth might be in negative zone or near zero in the current fiscal. Meanwhile, the RBI said in a report that the Covid-19 pandemic may erode fiscal consolidation gains achieved by the State governments in the past three years. Voting for the first phase of the Bihar Elections 2020 began this morning with Covid-19 precautions, while the second and third phases of elections will be held on November 3 and 7, respectively. The results will be declared on November 10. On the earnings front, Tata Motor’s Q2 loss widened from last year, but still beat analyst estimates. The company expects sales and production to improve in the second half of the current fiscal. Benchmark indexes Sensex and the Nifty jumped around 1 percent Tuesday and the rupee rose by 13 paise to 73.71 against the U.S. dollar after MSCI Inc. announced that it will make changes to its global indexes. Asian markets